Everything about HIV/AIDS management
These interim final results ended up statistically important and brought about ending the trial early to offer antiretroviral therapy to all participants during the standard-of-treatment team using a CD4 T-cell rely of lower than 350 cells/µL.
“it is a large amount to control,” he says. But Reid’s